Dragon Carries Experiments to ISS

KENNEDY SPACE CENTER, Fla. (CASIS PR) — Early Saturday morning at 2:48 a.m. EDT, a variety of payloads managed by the International Space Station (ISS) U.S. National Laboratory were successfully launched to the space station on SpaceX’s 17th commercial resupply services mission from the Cape Canaveral Air Force Station in Florida. Many of the ISS National Lab investigations included on this mission are aimed at improving human health on Earth, with several focused on drug development.

(more…)

SpaceX Dragon to Transport More than 20 ISS National Lab Experiments to ISS

KENNEDY SPACE CENTER, Fla, November 27, 2018 (SpaceX PR)– SpaceX is targeting no earlier than December 4 at 1:38 p.m. EST for its 16th commercial resupply mission (awarded by NASA) to the International Space Station  from Launch Complex 40 at Cape Canaveral Air Force Station.

SpaceX’s Dragon spacecraft will bring approximately 300 kilograms of research and hardware facilities to the orbiting laboratory under the International Space Station (ISS) U.S. National Laboratory flight allocation. There are more than 20 payloads included on this mission sponsored by the ISS National Lab.

(more…)

Small Tissue Chips in Space a Big Leap Forward for Research

Made of flexible plastic, tissue chips have ports and channels to provide nutrients and oxygen to the cells inside them. (Credits: NASA)

HOUSTON (NASA PR) — A small device that contains human cells in a 3D matrix represents a giant leap in the ability of scientists to test how those cells respond to stresses, drugs and genetic changes. About the size of a thumb drive, the devices are known as tissue chips or organs on chips.

A series of investigations to test tissue chips in microgravity aboard the International Space Station is planned through a collaboration between the National Center for Advancing Translational Sciences (NCATS) at the National Institutes for Health (NIH) and the Center for the Advancement of Science in Space (CASIS) in partnership with NASA. The Tissue Chips in Space initiative seeks to better understand the role of microgravity on human health and disease and to translate that understanding to improved human health on Earth.

(more…)

Human Physiology Projects Selected for International Space Station Research

KENNEDY SPACE CENTER, Fla., October 24, 2018 (CASIS PR) – The International Space Station (ISS) U.S. National Laboratory, the National Center for Advancing Translational Sciences (NCATS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB), today announced a series of project awards stemming from a funding opportunity on human physiology and disease onboard the orbiting laboratory. Both NCATS and NIBIB are part of the National Institutes of Health (NIH).

(more…)

CASIS, NIH Sponsor Human Physiology & Disease Experiments on ISS

KENNEDY SPACE CENTER, Fla., June 20, 2017 (CASIS PR The Center for the Advancement of Science in Space (CASIS) and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), today announced five grants have been awarded in response to a funding opportunity focused on human physiology and disease onboard the International Space Station (ISS) U.S. National Laboratory. Data from this research — which will feature “tissue chips” (or “organs-on-chips”) — will help scientists develop and advance novel technologies to improve human health here on Earth.

(more…)

CASIS, NCATS Announce ISS Funding Opportunities in Human Physiology

casis_new_logoKENNEDY SPACE CENTER, Fla., October 5, 2016 (CASIS PR) — The Center for the Advancement of Science in Space (CASIS) and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), today announced a funding opportunity focused on human physiology and disease onboard the International Space Station (ISS) U.S. National Laboratory. Data from this research — which will feature “tissue chips” (or “organs-on-chips”) — will help scientists develop and advance novel technologies to improve human health. This announcement is part of a four-year collaboration through which NCATS will provide up to $12 million in funding to use tissue chip technology for translational research onboard the ISS National Laboratory for the benefit of human health on Earth.

(more…)

CASIS, NIH Sign MOU to Study Human Physiology on ISS

casis_new_logoKENNEDY SPACE CENTER, Fla., July 12, 2016 (CASIS PR) — The Center for the Advancement of Science in Space (CASIS) and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), have established a Memorandum Of Understanding (MOU) to fund research into human physiology and disease on the International Space Station (ISS) U.S. National Laboratory. Data from this research — which will feature “Tissue Chips” (or “organs-on-chips”) — will help scientists develop and advance novel technologies to improve human health.

(more…)

CASIS Releases FY 2015 Annual Report

CASIS_2015_Annual_Report_CoverMELBOURNE, Fla. (CASIS PR) — We are pleased to share with you the FY2015 CASIS Annual Report.

As the managers of the International Space Station (ISS) U.S. National Laboratory, The Center for Advancement of Science in Space (CASIS) works closely with NASA and ISS National Lab partners to maximize the impact of research and development on the ISS to directly benefit life on Earth. Inside this year’s report you will find many signals of progress, as well as, unique perspectives from diverse ISS National Lab users.

FY2015 highlights include:

  • Receiving significant outside investments in ISS National Lab programming, including an agreement from the National Science Foundation to commit $1.8 million toward an ISS National Lab sponsored program, a $550,000 grant from the Massachusetts Life Sciences Center for flight and education projects, and more than $250,000 from the Boeing Company to match a CASIS partnership with the Mass Challenge Accelerator program.
  • Growing non-traditional user demand—the ISS National Lab reached full capacity for allocated crew time for research that was both scientifically and economically reviewed for Earth benefit.  These users included organizations like Merck, National Institutes of Health (NIH),  iExpressGenes, RasLabs, Massachusetts Institutes of Technology (MIT), Novartis. Visidyne and University of Florida.
  • Conducting the first-ever mouse bone-density scans in orbit—improving the capability to study bone and muscle loss in rodent models. Studying rodent models in space has been identified by researchers as an accelerated pathway to better treatments for osteoporosis and muscle atrophy on Earth.
  • Mounting of the first commercial platform on the exterior of the ISS for commercial testing of research payloads, sensors, and electronic components in space—created and sponsored by the ISS National Lab commercial service provider NanoRacks, LLC.

CASIS to Launch Immune Research Experiment to ISS

Video Caption: This video provides an overview of a CASIS/NASA/NIH investigation focused on immune suppression for aging adults by former astronaut Dr. Millie Hughes-Fulford. It will launch to the International Space Station on SpaceX-5 from Cape Canaveral Air Force Station, no earlier than December 19, 2014.

NIH to Spend $1.3 Million on ISS Biomedical Research

International Space Station

New Biology Research to Run on Space Station
Space.com

The International Space Station is about to take one giant leap for biological science in orbit.

Three new biomedical experiments funded by the U.S. National Institutes of Health will take advantage of the space station’s unique orbital facilities and weightless environment, NASA officials said. The experiments will use the station as a lab to study how bones and the immune system weaken in space.

(more…)